Merck and Moderna say skin cancer treatment shows promising results in a late-stage trial for melanoma

The treatment consists of mRNA coding tailored to a patient's biology.

Aug 20, 2026 - 20:00
 0  2
Merck and Moderna say skin cancer treatment shows promising results in a late-stage trial for melanoma
The treatment consists of mRNA coding tailored to a patient's biology.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow